Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00031135 · ClinicalTrials.gov registry record · Phase 2
Total Parenteral Nutrition-Associated Liver Disease
A Phase 2 study, sponsored by Northwestern University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 48
- Enrollment target
NCT00031135 is a Phase 2 study that was terminated before completion, run by Northwestern University. The registered enrollment target is 48 participants.
The verdict
NCT00031135, a Phase 2 study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 48 participants
- Enrollment target
Study Summary
This is a study to determine whether choline, when added to total parenteral nutrition (TPN), can help prevent the development of hepatic steatosis, a liver disease, in patients on TPN.
Interventions
- DRUG Choline Chloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2001-09 |
| Est. Completion | 2005-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00031135
The ClinicalTrials.gov registry entry for NCT00031135 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Choline Chloride is the first listed.
NCT00031135 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00031135 about?
NCT00031135 is a clinical study titled "Total Parenteral Nutrition-Associated Liver Disease". This is a study to determine whether choline, when added to total parenteral nutrition (TPN), can help prevent the development of hepatic steatosis, a liver disease, in patients on TPN.
What is the current status of trial NCT00031135?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 48 participants. The study started on 2001-09. Estimated completion is 2005-09.
What interventions are being tested in trial NCT00031135?
The interventions under investigation include: Choline Chloride (DRUG).
Who is sponsoring clinical trial NCT00031135?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.